Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xuanzhu Biopharmaceutical CoHKSE:02575 +3.21%11 Days Inventory is 1,188.29 as of Dec. 2025, which is 27% below its 10-year median of 1,623.76. GuruFocus rates HKSE:02575 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 920 Drug Manufacturers companies, Xuanzhu Biopharmaceutical Co ranks worse than 99.02% on this metric.
The historical rank and industry rank for Xuanzhu Biopharmaceutical Co's Days Inventory or its related term are showing as below:
HKSE:02575'
s Days Inventory Range Over the Past 10 Years
Min: 1293.69 Med: 1623.76 Max: 2487876.5
Current: 1293.69
During the past 3 years, Xuanzhu Biopharmaceutical Co's highest Days Inventory was 2487876.50. The lowest was 1293.69. And the median was 1623.76.
HKSE:02575's Days Inventory is ranked worse than 99.02% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.19
vs HKSE:02575: 1293.69
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Xuanzhu Biopharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.15.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xuanzhu Biopharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 2.06.
Xuanzhu Biopharmaceutical Co (HKSE:02575) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Xuanzhu Biopharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xuanzhu Biopharmaceutical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Xuanzhu Biopharmaceutical Co Days Inventory Related Terms
Xuanzhu Biopharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xuanzhu Biopharmaceutical Co Days Inventory Chart
Xuanzhu Biopharmaceutical Co Annual Data
Trend
Dec23
Dec24
Dec25
Days Inventory
2,487,876.50
1,623.76
1,406.10
Xuanzhu Biopharmaceutical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Days Inventory
0.00
1,311.48
2,178.40
1,299.28
1,188.29
HKSE:02575 vs ZTS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Xuanzhu Biopharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xuanzhu Biopharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Xuanzhu Biopharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Xuanzhu Biopharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xuanzhu Biopharmaceutical Co (HKSE:02575) has a Days Inventory of 1,188.29 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xuanzhu Biopharmaceutical Co and its competitors. This is 27% below median its historical median of 1,623.76. Over the past decade, Xuanzhu Biopharmaceutical Co's Days Inventory has ranged from 1,293.69 to 2,487,876.50. According to the industry distribution chart, Xuanzhu Biopharmaceutical Co ranks #911 out of 920 companies in the Drug Manufacturers industry, placing it in the top 99%.
Is Xuanzhu Biopharmaceutical Co's Days Inventory too high?
Xuanzhu Biopharmaceutical Co's current Days Inventory of 1,188.29 is 27% below median its 10-year median of 1,623.76. Over the past 10 years, this metric has ranged from a low of 1,293.69 to a high of 2,487,876.50. The Drug Manufacturers industry median Days Inventory is 165.19. Xuanzhu Biopharmaceutical Co's value of 1,188.29 is 619.3% above this industry median. Based on the distribution chart, Xuanzhu Biopharmaceutical Co ranks #911 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Xuanzhu Biopharmaceutical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Xuanzhu Biopharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Xuanzhu Biopharmaceutical Co ranks #911 out of 920 companies for Days Inventory. This places Xuanzhu Biopharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 165.19. Xuanzhu Biopharmaceutical Co's value of 1,188.29 is 619.3% above this benchmark. Historically, Xuanzhu Biopharmaceutical Co's own Days Inventory has ranged from 1,293.69 to 2,487,876.50 over the past decade. While the company's 10-year median is 1,623.76 vs. the industry median of 165.19, Xuanzhu Biopharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.19, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xuanzhu Biopharmaceutical Co's current Days Inventory of 1,188.29 is 619.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Xuanzhu Biopharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xuanzhu Biopharmaceutical Co's current Days Inventory is 1,188.29, which is 27% below median its own 10-year median of 1,623.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xuanzhu Biopharmaceutical Co stock overvalued right now?
Xuanzhu Biopharmaceutical Co (HKSE:02575) has a current Days Inventory of 1,188.29. The current Days Inventory is 1,188.29, which is 27% below median its 10-year median of 1,623.76 and 619.3% above the Drug Manufacturers industry median of 165.19. Xuanzhu Biopharmaceutical Co's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Xuanzhu Biopharmaceutical Co (HKSE:02575), the current Days Inventory is 1,188.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Xuanzhu Biopharmaceutical Co Ltd is an innovation-driven biopharmaceutical company in China, leveraging its understanding of China's pharmaceutical industry and insights of its clinical needs to improve patient health and life. It has over ten drug assets under active development covering digestive diseases, oncology, and NASH. Its track record also includes the successful development of four drug candidates that were subsequently transferred and/or out-licensed to pharmaceutical companies. Its pipeline is staggered and complementary in structure, covering both validated targets with druggability as well as new mechanisms of action and drug modalities, established therapeutic areas such as oncology, and high-growth potential therapeutic areas such as NASH.
11GF Score
Get the complete analysis for HKSE:02575
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02575 has been successfully added to your 
